Literature DB >> 19901339

RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction.

Kazuhiro Takuma1, Fang Fang, Wensheng Zhang, Shiqiang Yan, Emiko Fukuzaki, Heng Du, Alexander Sosunov, Guy McKhann, Yoko Funatsu, Noritaka Nakamichi, Taku Nagai, Hiroyuki Mizoguchi, Daisuke Ibi, Osamu Hori, Satoshi Ogawa, David M Stern, Kiyofumi Yamada, Shirley Shidu Yan.   

Abstract

Intracellular amyloid-beta peptide (Abeta) has been implicated in neuronal death associated with Alzheimer's disease. Although Abeta is predominantly secreted into the extracellular space, mechanisms of Abeta transport at the level of the neuronal cell membrane remain to be fully elucidated. We demonstrate that receptor for advanced glycation end products (RAGE) contributes to transport of Abeta from the cell surface to the intracellular space. Mouse cortical neurons exposed to extracellular human Abeta subsequently showed detectable peptide intracellularly in the cytosol and mitochondria by confocal microscope and immunogold electron microscopy. Pretreatment of cultured neurons from wild-type mice with neutralizing antibody to RAGE, and neurons from RAGE knockout mice displayed decreased uptake of Abeta and protection from Abeta-mediated mitochondrial dysfunction. Abeta activated p38 MAPK, but not SAPK/JNK, and then stimulated intracellular uptake of Abeta-RAGE complex. Similar intraneuronal co-localization of Abeta and RAGE was observed in the hippocampus of transgenic mice overexpressing mutant amyloid precursor protein. These findings indicate that RAGE contributes to mechanisms involved in the translocation of Abeta from the extracellular to the intracellular space, thereby enhancing Abeta cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19901339      PMCID: PMC2785285          DOI: 10.1073/pnas.0905686106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

Review 1.  RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease.

Authors:  Xi Chen; Douglas G Walker; Ann Marie Schmidt; Ottavio Arancio; Lih-Fen Lue; Shi Du Yan
Journal:  Curr Mol Med       Date:  2007-12       Impact factor: 2.222

2.  Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease.

Authors:  P Hemachandra Reddy; M Flint Beal
Journal:  Trends Mol Med       Date:  2008-01-22       Impact factor: 11.951

3.  The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae.

Authors:  Camilla A Hansson Petersen; Nyosha Alikhani; Homira Behbahani; Birgitta Wiehager; Pavel F Pavlov; Irina Alafuzoff; Ville Leinonen; Akira Ito; Bengt Winblad; Elzbieta Glaser; Maria Ankarcrona
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-29       Impact factor: 11.205

4.  Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction.

Authors:  Nicola Origlia; Massimo Righi; Simona Capsoni; Antonino Cattaneo; Fang Fang; David M Stern; John Xi Chen; Ann Marie Schmidt; Ottavio Arancio; Shi Du Yan; Luciano Domenici
Journal:  J Neurosci       Date:  2008-03-26       Impact factor: 6.167

Review 5.  Abeta-degrading enzymes in Alzheimer's disease.

Authors:  James Scott Miners; Shabnam Baig; Jennifer Palmer; Laura E Palmer; Patrick G Kehoe; Seth Love
Journal:  Brain Pathol       Date:  2008-04       Impact factor: 6.508

6.  Apolipoprotein E and low density lipoprotein receptor-related protein facilitate intraneuronal Abeta42 accumulation in amyloid model mice.

Authors:  Celina V Zerbinatti; Suzanne E Wahrle; Hyungjin Kim; Judy A Cam; Kelly Bales; Steven M Paul; David M Holtzman; Guojun Bu
Journal:  J Biol Chem       Date:  2006-09-29       Impact factor: 5.157

7.  Alzheimer's APP mangles mitochondria.

Authors:  Michael T Lin; M Flint Beal
Journal:  Nat Med       Date:  2006-11       Impact factor: 53.440

Review 8.  Intracellular amyloid-beta in Alzheimer's disease.

Authors:  Frank M LaFerla; Kim N Green; Salvatore Oddo
Journal:  Nat Rev Neurosci       Date:  2007-07       Impact factor: 34.870

9.  Interaction of amyloid binding alcohol dehydrogenase/Abeta mediates up-regulation of peroxiredoxin II in the brains of Alzheimer's disease patients and a transgenic Alzheimer's disease mouse model.

Authors:  Jun Yao; Margaret Taylor; Fleur Davey; Yimin Ren; Jim Aiton; Peter Coote; Fang Fang; John Xi Chen; Shi Du Yan; Frank J Gunn-Moore
Journal:  Mol Cell Neurosci       Date:  2007-04-01       Impact factor: 4.314

10.  Endophilin I expression is increased in the brains of Alzheimer disease patients.

Authors:  Yimin Ren; Hong Wei Xu; Fleur Davey; Margaret Taylor; Jim Aiton; Peter Coote; Fang Fang; Jun Yao; Doris Chen; John Xi Chen; Shi Du Yan; Frank J Gunn-Moore
Journal:  J Biol Chem       Date:  2007-12-31       Impact factor: 5.157

View more
  126 in total

1.  Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice.

Authors:  Latha Devi; Masuo Ohno
Journal:  Neurobiol Dis       Date:  2011-09-13       Impact factor: 5.996

2.  A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.

Authors:  Rashid Deane; Itender Singh; Abhay P Sagare; Robert D Bell; Nathan T Ross; Barbra LaRue; Rachal Love; Sheldon Perry; Nicole Paquette; Richard J Deane; Meenakshisundaram Thiyagarajan; Troy Zarcone; Gunter Fritz; Alan E Friedman; Benjamin L Miller; Berislav V Zlokovic
Journal:  J Clin Invest       Date:  2012-03-12       Impact factor: 14.808

Review 3.  Synaptic mitochondrial pathology in Alzheimer's disease.

Authors:  Heng Du; Lan Guo; Shirley ShiDu Yan
Journal:  Antioxid Redox Signal       Date:  2011-12-15       Impact factor: 8.401

4.  Microglial receptor for advanced glycation end product-dependent signal pathway drives beta-amyloid-induced synaptic depression and long-term depression impairment in entorhinal cortex.

Authors:  Nicola Origlia; Camilla Bonadonna; Alfredo Rosellini; Elena Leznik; Ottavio Arancio; Shirley Shidu Yan; Luciano Domenici
Journal:  J Neurosci       Date:  2010-08-25       Impact factor: 6.167

5.  The p38 MAP Kinase Family as Regulators of Proinflammatory Cytokine Production in Degenerative Diseases of the CNS.

Authors:  Adam D Bachstetter; Linda J Van Eldik
Journal:  Aging Dis       Date:  2010-09-24       Impact factor: 6.745

6.  Perforin Promotes Amyloid Beta Internalisation in Neurons.

Authors:  Erica Lana; Mahbod Khanbolouki; Charline Degavre; Eva-Britt Samuelsson; Elisabet Åkesson; Bengt Winblad; Evren Alici; Christina Unger Lithner; Homira Behbahani
Journal:  Mol Neurobiol       Date:  2016-01-16       Impact factor: 5.590

Review 7.  Amyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer's disease.

Authors:  Tae-In Kam; Youngdae Gwon; Yong-Keun Jung
Journal:  Cell Mol Life Sci       Date:  2014-08-24       Impact factor: 9.261

8.  Decreased proteolytic activity of the mitochondrial amyloid-β degrading enzyme, PreP peptidasome, in Alzheimer's disease brain mitochondria.

Authors:  Nyosha Alikhani; Lan Guo; Shiqiang Yan; Heng Du; Catarina Moreira Pinho; John Xi Chen; Elzbieta Glaser; Shirley ShiDu Yan
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

9.  Structure-based design and synthesis of benzothiazole phosphonate analogues with inhibitors of human ABAD-Aβ for treatment of Alzheimer's disease.

Authors:  Koteswara R Valasani; Gang Hu; Michael O Chaney; Shirley S Yan
Journal:  Chem Biol Drug Des       Date:  2012-11-14       Impact factor: 2.817

10.  Blocking the interaction between apolipoprotein E and Aβ reduces intraneuronal accumulation of Aβ and inhibits synaptic degeneration.

Authors:  Magdalena A Kuszczyk; Sandrine Sanchez; Joanna Pankiewicz; Jungsu Kim; Malgorzata Duszczyk; Maitea Guridi; Ayodeji A Asuni; Patrick M Sullivan; David M Holtzman; Martin J Sadowski
Journal:  Am J Pathol       Date:  2013-03-13       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.